Skip to content

Casein in milk as a functional ingredient for the prevention of sarcopenia

Casein in milk as a functional ingredient for the prevention of sarcopenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20646
Enrollment
32
Registered
2014-02-06
Start date
2014-04-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Interventions

Subjects will be randomly assigned to consume either a drink containing isolated casein or casein in the normal milk matrix. By the use of stable isotope methodology we will assess the digestion and a

Sponsors

Maastricht University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Males - Aged between 65-85 years - Healthy, recreationally active - BMI < 30 kg/m2

Exclusion criteria

Exclusion criteria: - Female - Smoking - Allergies to milk proteins (whey or casein) - Arthritic conditions - Over the counter antacids - Diabetes mellitus type 1 and type 2 - A history of neuromuscular problems - Individuals on any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications). - Participation in any regular exercise program - Chronic use of gastric acid suppressing medication or anti-coagulants - Unstable weight over the last three months - Pathologies of the gastrointestinal tract

Design outcomes

Primary

MeasureTime frame
fractional synthetic rate

Secondary

MeasureTime frame
• Exogenous phenylalanine rate of appearance and plasma availability of phenylalanine. • Total rate of phenylalanine appearance and disappearance • Endogenous phenylalanine rate of appearance

Contacts

Public ContactL.J.C. Loon, van

Capaciteitsgroep Human Biology, room 2.356, Universiteitssingel 50

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)